Harvard Bioscience (HBIO) Gross Profit Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 21.17% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 3.58% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 20.68% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 5.02% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 16.27% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 20.19% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 9.45% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 8.29% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 4.14% |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 9.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.51% |
| Mar 31, 2026 | 0.49% |
| Dec 31, 2025 | 1.15% |
| Sep 30, 2025 | -5.83% |
| Jun 30, 2025 | -12.75% |
| Mar 31, 2025 | -17.52% |
| Dec 31, 2024 | -14.17% |
| Sep 30, 2024 | -13.32% |
| Jun 30, 2024 | -20.72% |
| Mar 31, 2024 | -19.48% |
| Dec 31, 2023 | 3.11% |
| Sep 30, 2023 | 20.99% |
| Jun 30, 2023 | 0.22% |
| Mar 31, 2023 | 13.41% |
| Dec 31, 2022 | -19.05% |
| Sep 30, 2022 | -25.36% |
| Jun 30, 2022 | 1.74% |
| Mar 31, 2022 | 4.83% |
| Dec 31, 2021 | 10.46% |
| Sep 30, 2021 | 20.84% |